PCBL Chemical Limited — Others, 29-04-2025: Statement of deviation(s) or variation(s) under Reg. 32

PCBL Chemical Limited confirmed that there is no deviation in the use of proceeds from the allotment of 1.6 crore convertible warrants, which converted into equity shares. The company raised ₹112 crore initially, with an additional ₹336 crore expected within 18 months as warrant holders exercise their rights. As of the quarter ended March 31, 2025, no warrants were exercised, maintaining total proceeds at ₹112 crore, fully utilized up to September 2024. This update reflects the company's financial discipline and commitment to its planned capital allocation, reassuring stakeholders.